Both adenoma and stage I/II CRC patients contained the highest anti-RpL7/L12 titers, which were significantly different from those of healthy individuals and advanced stage CRC patients, suggesting a temporal relation with early stage colonic lesions. The gene discussed is RPL7; the disease is colorectal carcinoma.